EDGAR Filing Documents for 0001144204-17-057793

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001144204-17-057793

Filing Date

2017-11-09

Accepted

2017-11-09 16:50:52

Documents

Period of Report

2017-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	tv477933_10q.htm	10-Q	824531
2	EXHIBIT 31.1	tv477933_ex31-1.htm	EX-31.1	9352
3	EXHIBIT 31.2	tv477933_ex31-2.htm	EX-31.2	9339
4	EXHIBIT 32.1	tv477933_ex32-1.htm	EX-32.1	3895
5	EXHIBIT 32.2	tv477933_ex32-2.htm	EX-32.2	3771
	Complete submission text file	0001144204-17-057793.txt		6844985

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	eltp-20170930.xml	EX-101.INS	1657813
7	XBRL TAXONOMY EXTENSION SCHEMA	eltp-20170930.xsd	EX-101.SCH	67468
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	eltp-20170930_cal.xml	EX-101.CAL	39174
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	eltp-20170930_def.xml	EX-101.DEF	398008
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	eltp-20170930_lab.xml	EX-101.LAB	443571
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	eltp-20170930_pre.xml	EX-101.PRE	460225

Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647

Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646

ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)